title: What information should be required to support clinical "omics" publications?
authors.affiliation: Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. kabagg@mdanderson.org
authors.forename: Keith A
authors.initials: KA
authors.lastname: Baggerly
authors.forename: Kevin R
authors.initials: KR
authors.lastname: Coombes
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D035843:Biomedical Research / Q000592:standards*; D002986:Clinical Trials as Topic; D020869:Gene Expression Profiling / Q000592:standards*; D023281:Genomics / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis / Q000592:standards; D010506:Periodicals as Topic / Q000592:standards*; D057285:Precision Medicine / Q000592:standards; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards*
chemical_list: D000970:Antineoplastic Agents